Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe RheumatoId Arthritis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT06726096
What this trial is testing

Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Anti IL-6R
Beijing VDJBio Co., LTD. 615
Large-scale testing (Phase 3)WithdrawnNCT04680962
What this trial is testing

MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Mabion SA
Large-scale testing (Phase 3)Ended earlyNCT05246280
What this trial is testing

Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA

Who this might be right for
Rheumatoid Arthritis
Navidea Biopharmaceuticals 169
Large-scale testing (Phase 3)Study completedNCT01951170
What this trial is testing

An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 52
Large-scale testing (Phase 3)Study completedNCT02638259
What this trial is testing

Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sandoz 376
Testing effectiveness (Phase 2)Study completedNCT02983227
What this trial is testing

Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 496
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748728
What this trial is testing

TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs

Who this might be right for
Rheumatoid Arthritis (RA)
Hangzhou Highlightll Pharmaceutical Co., Ltd 90
Large-scale testing (Phase 3)Study completedNCT01223365
What this trial is testing

Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time

Who this might be right for
Chronic Pain
Teva Branded Pharmaceutical Products R&D, Inc. 330
Not applicableStudy completedNCT05327920
What this trial is testing

An Observational Study to Assess the Impact of Upadacitinib in Adult Hungarian Participants With Moderate to Severe Rheumatoid Arthritis (RA) in Real-World Practice

Who this might be right for
Rheumatoid Arthritis
AbbVie 93
Post-approval studies (Phase 4)Study completedNCT02187055
What this trial is testing

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

Who this might be right for
Rhematoid Arthritis
Pfizer 1,152
Large-scale testing (Phase 3)Active Not RecruitingNCT04539964
What this trial is testing

Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SetPoint Medical Corporation 243
Testing effectiveness (Phase 2)Ended earlyNCT02862574
What this trial is testing

Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 15
Testing effectiveness (Phase 2)Study completedNCT05247216
What this trial is testing

Hemay007 in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Tianjin Hemay Pharmaceutical Co., Ltd 140
Large-scale testing (Phase 3)Study completedNCT02675426
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone

Who this might be right for
Rheumatoid Arthritis
AbbVie 661
Not applicableStudy completedNCT01086033
What this trial is testing

A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece

Who this might be right for
Rheumatoid Arthritis
AbbVie (prior sponsor, Abbott) 566
Large-scale testing (Phase 3)Study completedNCT02744755
What this trial is testing

Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sandoz 353
Testing effectiveness (Phase 2)WithdrawnNCT02795299
What this trial is testing

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bird Rock Bio, Inc.
Large-scale testing (Phase 3)Ended earlyNCT01955733
What this trial is testing

Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Boehringer Ingelheim 91
Testing effectiveness (Phase 2)Study completedNCT01851707
What this trial is testing

Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone

Who this might be right for
Rheumatoid Arthritis
SecuraBio 322
Large-scale testing (Phase 3)Study completedNCT01734993
What this trial is testing

A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 11
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation